Editorial · 30 Mar 2025
Short communicationPublished 26 Nov 2020
Pharmaceutical innovations and medical knowledge on diabetes for T2DM treatments: A short communication
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pathogenesis and therapeutics of type 2 diabetes are currently too refractory to be easily managed in the clinics. Medical knowledge and therapeutic options for T2DM treatments are still of great medical significance. We welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments in future.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes & Clinical Practice.
Editorial · 30 Mar 2025
Tobacco and Nicotine Addiction Research: Insights for Diabetes and Clinical Practice
Editorial · 30 Mar 2025
Developments in Diabetes and Clinical Practice
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Clinical Practice
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Chakraborty N”